<DOC>
	<DOCNO>NCT02182661</DOCNO>
	<brief_summary>The objective study investigate long-term safety Ba253BINEB . Secondarily long-term efficacy Ba253BINEB also investigate .</brief_summary>
	<brief_title>A Long-term Study Ba253BINEB Patients With Bronchial Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Oxitropium</mesh_term>
	<criteria>The patient bronchial asthma satisfy follow criterion 1 . Patients age &gt; = 20 year old 2 . Patients mild moderate severity 3 . Patients must able understand patient information form 1 . Patients take long acting corticosteroid ( i.m . ) within 1 month screen test 2 . Patients use corticosteroid medication ( p.o./ i.h . ) dose excess equivalent 10 mg/day prednisolone 3 . Patients glaucoma 4 . Patients prostatic hypertrophy 5 . Patients hypersensitivity anticholinergic drug 6 . Patients begin treatment hyposensitization immunoregulator therapy within 3 month screen test 7 . Patients complicate chronic bronchitis , emphysema bronchiectasis , make assessment drug efficacy bronchial asthma difficult 8 . Patients serious hepatic disease , kidney disease heart disorder judge investigator inappropriate subject study 9 . Women pregnant may become pregnant , nursing woman 10 . Patients judge investigator inappropriate subject study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>